Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression profile of LMSU gastric cancer cell p53 KO and KD

ABSTRACT: LMSU gastric cancer cells were manipulated to either knockout or knockdown mutant p53-R175H, which is endogenously mutated and expressed in this cell line.

ORGANISM(S): Homo sapiens

PROVIDER: GSE132331 | GEO | 2019/06/07

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Gene expression profile of gastric organoids p53 KO and KD

Project description:Gastric organoids were manipulated to knockout p53

2019-12-10 | GSE141625 | GEO

Gene expression profile of HGC27 gastric cancer cell p53 KO and KD

Project description:HGC27 gastric cancer cells were manipulated to express mutant p53

2019-06-07 | GSE132333 | GEO

Gene expression profile of gastric organoids p53 KO and KD

Project description:Gene expression profile of gastric organoids p53 KO and KD

| PRJNA594201 | ENA

Human glioblastoma cells: Tet-on(mutant p53 R175H expression) vs Tet-off(p53-null)

Project description:TP53 R175H mutation is one of the most common mutations in human cancers and cancer cells with this mutation stably express R175H protein in the nucleus. To identify the synthetic lethal gene interacted with the R175H, we conducted the high throughput screening by using tetracyclin inducible R175H expression system in SF126 cells and comprehensive shRNA library carried by lenti virus. We identified 906 candidate gene suppressions that may lead to accelerated cell growth inhibition under the presence of R175H. Inhibitor of differentiation 1 (ID1) was one of the candidate genes and suppression of ID1 by siRNA resulted in acceleration of growth inhibition of cell lines expressing endogenous R175H but not in TP53 null cell lines. The transient expression of R175H in TP53 null cell lines and suppression of ID1 and/or TP53 R175H in cell lines with endogenous R175H revealed that the cell growth inhibition by ID1 suppression was dependent on R175H expression but not other common p53 mutants (R273H). Flow cytometric (FACS) analysis exhibited that ID1 suppression resulted in G1 arrest and the arrest was accelerated by suppression of R175H. In conclusion, ID1 is a synthetic lethal gene interacted with R175H and is considered to be a novel molecular target of cancer therapy for R175H expressing cells. R175H expression(Tet-on) group was labeled by Cy5, and p53-null(Tet-off) group was labeled by Cy3. Three independent experiments were conducted (We have triplicate data).

2011-11-02 | E-GEOD-33362 | biostudies-arrayexpress

Gene expression profile of HGC27 gastric cancer cell p53 KO and KD

Project description:Gene expression profile of HGC27 gastric cancer cell p53 KO and KD

| PRJNA547629 | ENA

Gene expression profile of LMSU gastric cancer cell p53 KO and KD

Project description:Gene expression profile of LMSU gastric cancer cell p53 KO and KD

| PRJNA547627 | ENA

USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells

Project description:Gain-of-function p53 mutants such as p53-R175H form stable aggregates that accumulate in cells and play an important role in cancer progression. Selective degradation of gain-of-function p53 mutants has emerged as a highly attractive therapeutic strategy to target cancer cells harboring specific p53 mutations. We identified a small molecule called MCB-613 to cause rapid ubiquitination, nuclear export, and degradation of p53-R175H through lysosome-mediated pathway leading to catastrophic cancer cell death. In contrast to its effect on the p53-R175H mutant, MCB-613 causes slight stabilization of p53-WT and has weaker effects on other p53 gain-of-function mutants. Using state-of-the-art genetic and chemical approaches, we identified the deubiquitinase USP15 as the mediator of MCB-613’s effect on p53-R175H and established USP15 as a selective upstream regulator of p53-R175H in ovarian cancer cells. These results confirm that distinct pathways regulate the turnover of p53-WT and the different p53 mutants and open new opportunities to selectively target them.

2018-02-07 | GSE110220 | GEO

mutant p53-interacting proteins analyzed by LC-MS/MS

Project description:p53-/- HCT116 cells transduced with the control empty vector or vectors expressing wtp53 or R175H mutp53 were employed for co-IP followed by LC-MS/MS analysis. The potential wtp53 or R175H mutp53-interacting proteins are listed.

2024-08-12 | MSV000095580 | MassIVE

Human glioblastoma cells: Tet-on(mutant p53 R175H expression) vs Tet-off(p53-null)

2011-11-02 | GSE33362 | GEO

Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD

Project description:Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD

| PRJNA547624 | ENA